Hodgkin's Lymphoma

Hodgkin's lymphoma, previously known as Hodgkin's disease, is a type of lymphoma, which is a type of cancer originating from white blood cells called lymphocytes. It was named after Thomas Hodgkin, who first described abnormalities in the lymph system in 1832.

What is Hodgkin's Lymphoma?

Hodgkin’s lymphoma or Hodgkin’s disease is a form of cancer that affects the lymphatic system. The cancer originates in the lymphocytes, which are white blood cells. The disease was so named after Thomas Hodgkin, who first described the condition in 1832.

Hodgkin's Lymphoma Classification

Hodgkin's Lymphoma Diagnosis

Hodgkin's Lymphoma Pathology

Hodgkin's Lymphoma Prognosis

Hodgkin's Lymphoma Treatment

Hodgkin's Lymphoma Epidemiology

Hodgkin's Lymphoma History

Hodgkin's Lymphoma Symptoms

Latest Hodgkin's Lymphoma News and Research

Immunotherapy sets new standard for Hodgkin lymphoma care

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent, suggesting a new standard therapy for the disease.

16 Oct 2024

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government's Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

3 Oct 2024

New advances in Hodgkin's lymphoma treatment offer hope for affected individuals

Hodgkin's lymphoma (HL), impacting the lymph nodes and lymphatic system, has experienced a gradual increase in survival rates thanks to contemporary chemotherapy.

13 Aug 2024

Researchers find the effect of pesticides on increased cancer risk is comparable to smoking for some cancers

Researchers comprehensively evaluated the impact of pesticide use on cancer development in the United States.

29 Jul 2024

Heart transplant recipient's journey: From patient to advocate

Glen Kelley's journey as a heart transplant recipient came full circle today in Prague, as he addressed attendees of the Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), including members of his own care teams.

12 Apr 2024

Phase I clinical trial of new CAR T cell therapy AT101 shows promising early responses

Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct binding mechanism to target CD19, show a 100 percent complete response (CR) rate at the higher dose levels studied in the trial, according to researchers from the University of Pennsylvania Perelman School of Medicine and Penn Medicine's Abramson Cancer Center.

11 Dec 2023

High BMI in late teens linked to higher risk of 17 different cancers later in life

Men who are overweight or obese at age 18 have a higher risk of 17 different cancers later in life. This has been shown in a study at the University of Gothenburg.

6 Nov 2023

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

Researchers examined the association between moderate alcohol intake and specific cancer risks.

21 Aug 2023

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

A new research paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair."

13 Jun 2023

2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

The Pediatric Cancer Research Foundation, a nonproﬁt focused on transforming pediatric cancer care by accelerating research breakthroughs, today announced the 19 recipients of its 2023 research grants.

26 May 2023

Formerly incarcerated persons have higher health risks than the general population

In 2012, Michael Cruz exercised a lot. Four years into a 15-year prison sentence, this was one of the only things he had, he says, until he noticed a numb, tingling sensation in one of his toes while working out.

3 Apr 2023

Chemotherapy in the afternoon proved to be effective for female lymphoma patients

Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword. While the drugs are highly effective at killing cancer cells, they are also notorious for killing healthy cells in the body.

27 Jan 2023

Researchers discover a highly potent biomarker for clinical response to CAR-T cell therapy

A MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequisites for optimal use of this novel therapy for lymphoma treatment.

9 Jan 2023

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) in New York have discovered that common cancer treatments, such as radiotherapy or anthracycline drugs, cause long-term damage to heart tissue by activating a key inflammatory signaling pathway.

19 Dec 2022

Addition of brentuximab vedotin to chemotherapy has a positive impact for patients with Hodgkin lymphoma

A study led by researchers from Mayo Clinic Comprehensive Cancer Center has found that the addition of brentuximab vedotin to standard chemotherapy treatment improves overall survival in patients with Hodgkin Lymphoma, when compared to the current standard of chemotherapy alone.

14 Jul 2022

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Stand Up To Cancer and Zentalis Pharmaceuticals, Inc. today announced that Zentalis will contribute $1 million to the SU2C Catalyst program to support research that investigates the use of certain small molecule inhibitors for treating a variety of cancer types.

15 Mar 2022

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

The Damon Runyon Cancer Research Foundation has announced its newest cohort of Damon Runyon Fellows, 13 outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators.

29 Jan 2022

International collaboration secures €1M grant to investigate new treatment target for lymphoma

An international collaboration involving researchers from Queen Mary University of London, Memorial Sloan Kettering Cancer Center, New York and Dana-Farber Cancer Institute, Boston has secured a €1M research grant from Dutch blood cancer charity, Lymph&Co, to investigate a new treatment target for lymphoma.

25 Nov 2021

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

A research group from the US (led by experts from Yale University School of Medicine) recently presented a case of an immunocompromised female patient with acquired deficiency of B lymphocytes who subsequently developed a protracted course of the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

10 Nov 2021

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Israeli researchers evaluate the antibody response in ICPs to assess antibody-mediated immunity following vaccination with the Pfizer-BioNTech vaccine.

26 Oct 2021

Hodgkin's Lymphoma

Overview

Hodgkin's Lymphoma Classification

Hodgkin's Lymphoma Diagnosis

Hodgkin's Lymphoma Pathology

Feature Articles

Hodgkin's Lymphoma Prognosis

Hodgkin's Lymphoma Treatment

Hodgkin's Lymphoma Epidemiology

Hodgkin's Lymphoma History

Hodgkin's Lymphoma Symptoms

Latest Hodgkin's Lymphoma News and Research

Immunotherapy sets new standard for Hodgkin lymphoma care

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

New advances in Hodgkin's lymphoma treatment offer hope for affected individuals

Researchers find the effect of pesticides on increased cancer risk is comparable to smoking for some cancers

Heart transplant recipient's journey: From patient to advocate

Phase I clinical trial of new CAR T cell therapy AT101 shows promising early responses

High BMI in late teens linked to higher risk of 17 different cancers later in life

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

Formerly incarcerated persons have higher health risks than the general population

Chemotherapy in the afternoon proved to be effective for female lymphoma patients

Researchers discover a highly potent biomarker for clinical response to CAR-T cell therapy

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Addition of brentuximab vedotin to chemotherapy has a positive impact for patients with Hodgkin lymphoma

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

International collaboration secures €1M grant to investigate new treatment target for lymphoma

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Hodgkin's Lymphoma

Overview

Feature Articles

Hodgkin's Lymphoma Prognosis

Hodgkin's Lymphoma Treatment

Hodgkin's Lymphoma Epidemiology

Hodgkin's Lymphoma History

Hodgkin's Lymphoma Symptoms

Latest Hodgkin's Lymphoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in